Journey Medical Corporation - Common Stock (DERM)
4.9250
+0.2350 (5.01%)
NASDAQ · Last Trade: Apr 1st, 12:36 PM EDT
Top movers analysis one hour before the close of the markets on 2026-03-26: top gainers and losers in today's session.chartmill.com
Via Chartmill · March 26, 2026
Journey Medical Corp (NASDAQ:DERM) Shares Drop 8.8% After Q4 Revenue Misschartmill.com
Via Chartmill · March 25, 2026
Via Benzinga · November 12, 2025
Via Benzinga · August 13, 2025
Via Benzinga · August 13, 2025
Wondering what's happening in Wednesday's pre-market session? Find an overview in this article.
Via Chartmill · August 13, 2025
Via Benzinga · August 13, 2025
Shares of Sapiens International Corporation NV (NASDAQ:SPNS) rose sharply in pre-market trading after it announced on Wednesday that it will be acquired by global private equity firm Advent in an all-cash transaction
Via Benzinga · August 13, 2025
Via Benzinga · August 12, 2025
After the closing bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via Chartmill · August 12, 2025
Via Benzinga · June 11, 2025

Via Benzinga · November 29, 2024

Via Benzinga · November 4, 2024

Journey Medical (NASDAQ:DERM) shares are trading higher Monday after the company announced the U.S. Food and Drug Administration approved its Emrosi drug for the treatment of rosacea.
Via Benzinga · November 4, 2024

DERM stock results show that Journey Medical missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 12, 2024

Via Benzinga · June 10, 2024

DERM stock results show that Journey Medical beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 13, 2024

Biotech stocks can offer some of the most explosive, exciting opportunities on the market.That is, if you find the right one.
Via InvestorPlace · April 11, 2024